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Role of hypoalbuminemia and hypocholesterolemia as co- Mortality associated with acute renal failure (ARF)
predictors of mortality in acute renal failure. remains high despite recent advances in critical care
Background. Hypoalbuminemia (LA) and hypocholesterol- medicine, renal replacement therapy, use of biocompati-
emia (LC) have been reported to portend high mortality in ble dialysis membranes, and nutritional support. The mor-
both older patients and in patients with end-stage renal disease.
tality rates vary from 25 to 90% depending on the severityEven though low levels have been reported in critically ill
of illness and hospital setting [1–7]. The use of logisticpatients, they have not been clearly defined as predictors of
regression models has enabled many investigators to esti-mortality in acute renal failure (ARF). The impact of LA and
LC on mortality in ARF is evaluated in this study. mate the risks of mortality associated with numerous out-
Methods. We conducted a computer-assisted three-year ret- come predictors. The major adverse outcome predictors
rospective review of all cases of de novo ARF seen at an inner are: sepsis, underlying disease, multiorgan dysfunction
city tertiary-care facility. One hundred cases met the criteria state (MODS), oliguria, hyperbilirubinemia, mechanical
for inclusion in the study. We employed both univariate and ventilation, cardiovascular complications, and severitymultivariate logistic regression models to estimate the relative
of illness, as assessed by use of Acute Physiology andrisks (RR) and 95% confidence intervals (CI) of mortality
Chronic Health Evaluation Scores (APACHE) [1, 4, 7].associated with several variables.
Although hypoalbuminemia (LA) and hypocholester-Results. Predictors associated with a high risk of death iden-
tified in this study include LC # 150 mg/dl (# 3.9 mmol/liter; olemia (LC) have been reported to be independent pre-
RR, 7.4; CI, 2.7 to 20.3), LA # 35 g/liter (RR, 5.0; CI, 1.9 to dictors of high mortality in both older patients and pa-
13.2), sepsis (RR, 9.4; CI, 3.7 to 23.9), mechanical ventilation tients with end-stage renal disease (ESRD) [8–11], there
(RR, 10.8; CI, 2.8 to 41.0), oliguria (RR 17.0; CI, 6.2 to 46.6), is paucity of information in the literature concerning the
and multisystem organ failure (RR 24.7; CI, 10.3 to 59.1). The
presence or absence of an association between LA andoverall gross mortality was 39%, but mortality among intensive
LC with mortality in ARF. Hypoalbuminemia was re-care unit patients was 82%. Survival was 82% among patients
cently reported by Chertow et al as a predictor of mortal-with serum albumin . 35 g/liter versus 48% among those with
serum albumin # 35 g/liter (x2 5 11.9, P 5 0.0006). Similarly, ity with a relative risk (RR) of 0.56 in their patients
survival was higher among patients with cholesterol . 150 mg/dl with acute tubular necrosis (ATN) [1]. In this study,
(. 3.9 mmol/liter) than those whose levels were # 150 mg/dl we identified several previously reported predictors of
(# 3.9 mmol/liter; 85 vs. 44%, x2 5 17.3, P , 0.0001). Significant mortality in ARF and confirmed their association with
association between LA and LC was observed (R 5 0.4, P ,
mortality, but, in addition, observed a consistent associa-0.0001). Age, gender, level of plasma creatinine, and underlying
tion between hypoalbuminemia and hypocholesterole-chronic medical conditions were not predictive of mortality.
mia with mortality. The effect of LA and LC on mortalityConclusion. Survival in ARF is significantly altered by the
in de novo ARF has not been previously reported, to ourlevels of albumin and cholesterol. Because both LC and LA
can be cytokine mediated, their presence in ARF should be knowledge. Patients with pre-existing renal insufficiency
considered ominous. were excluded so that any underlying LA and LC would
not constitute confounding variables.
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Table 1. Demographic, clinical and select laboratory profiles of thea three-year (1994 to 1996) computer-assisted retrospec-
study patients
tive review of all hospital discharges classified as ARF,
Characteristic Valuerenal failure, ATN, and acute tubulointerstitial nephritis.
Age years 53.7619.9Two hundred and forty cases of ARF were identified,
Gender M, % 65and their charts were retrieved and reviewed in depth.
Seight kg 65.1615.8
Exclusion criteria were: age #18; all obstetric related MAP mm Hg 87.3619.6
Peak plasma creatinine mg/dl (lmol /liter) 5.663.9 (445 6344.8)cases of ARF, pre-existing chronic renal insufficiency
Albumin g /liter 3168with serum creatinine $1.7 mg/dl (150 mmol/liter); all
Cholesterol mg/dl (mmol /liter) 148.3651.8 (3.9 61.4)
cases documented as acute-on chronic renal failure; all Sepsis % 45
Oliguria % 40cases of glomerulonephritis; and all patients whose eleva-
Dehydration % 49tion in serum creatinine resolved within 48 hours. Pa-
Dialysis % 10
tients with incomplete records and those who left the MODS % 32
Mortality % 39hospital prematurely without follow-up arrangements
were also excluded. Abbreviations are: MODS, multiple organ dysfunction states; MAP, mean
arterial pressure.Inclusion criteria were as follows: serum creatinine
elevation of at least 0.5 mg/dl (44 mmol/liter) and $2.0
mg/dl (177 mmol/liter) when baseline value was ,1.7
mg/dl (150 mmol/liter) and serum creatinine $2.0 mg/dl significant association (at P , 0.05) were re-analyzed
(177 mmol/liter) at the time of presentation when no using a multivariate logistic regression model. Variables
prior history of ARF was available. were included by an automated format. Goodness of fit
A total of 100 of the 240 ARF cases satisfied the statistics were based on a comparison of the model to a
criteria for inclusion in this study. Demographic, bio- saturated model that allowed outcome variable to vary
chemical, and clinical profiles of all patients were noted. arbitrarily over all distinct levels of the independent vari-
Sepsis was considered to be present when positive blood ables. Final step selections were based on a model fit
cultures were documented with or without elevated tem- that yielded a likelihood ratio with a P value , 0.05.
perature $ 388C and/or presence of hypotension. Oligu- Model discrimination or the ability to distinguish pa-
ria was defined as urine output of #400 ml/day. Multiple tients who died from those who survived was based on
organ dysfunction state (MODS) was considered present an automated estimated probability of mortality using a
when ARF was coupled with several other dysfunctional prior probability of 0.5 and a 2 3 2 logistic classification
organ systems such as respiratory failure with the use of table, which corresponded to the receiver operating char-
mechanical ventilation or decreased PO2/FI02 ratio; liver acteristic curve (ROC), as described by Lemeshow and
failure (with elevated bilirubin and transaminases), coma, Le Gall [13]. Coefficient of binary variables and their
or seizure disorder; myocardial infarction, use of multiple standard errors were used to calculate the RRs of death
pressors for cardiovascular support and dysrhythmias; and their 95% confidence interval (95% CI). Censoring
and hematologic dysfunction with coagulopathy, anemia, of events was made at 120 days based on a 90-day maxi-
and or thrombocytopenia. The scoring of MODS was mum hospital stay plus a 30-day posthospital discharge
based on modification of the format designed by Mar- follow-up. Kaplan–Meier survival plots were employed
shall et al [12]. An all-or-none semiquantitative score to show survival trends associated with both hypoalbumi-
derived from the intensive care unit (ICU) admission nemia and hypocholesterolemia. The software package
value and cumulative values over entire ICU stay were “Statview” (SAS Institute, Inc., Cary, NC, USA) was
used for analysis (D MODS). Patients with scores $12 used for all analyses.
or $3 organ system involvement were classified as
MODS for comparative analysis. No comparison was
RESULTSmade between various scores and mortality.
All of the patients in this study were African Ameri-
Analysis cans aged 20 to 93 years. Thirty-five percent of the pa-
tients were #40 years old, whereas 38% were $64 yearsContinuous variables are reported as mean 6 sd. Chi
square (x2) was used for intragroup comparison of nomi- old. Table 1 lists many of the demographic and clinical
profiles of the patients. The reported albumin, choles-nal variables. Univariate logistic regression analyses
were performed on 17 independent variables to explore terol, and mean arterial pressure (MAP) levels represent
readings obtained at admission. The serum albumintheir effect on the outcome of interest, which in this study
was “mortality.” These variables included age, gender, ranged from 13 to 49 g/liter, whereas the cholesterol
ranged from 58 to 290 mg/dl (1.5 to 7.5 mmol/liter). Theserum creatinine, serum albumin, cholesterol and elec-
trolytes, sepsis, use of mechanical ventilation, oliguria, serum creatinine ranged from 2.0 to 22 mg/dl (177 to
1944.8 mmol/liter). Ten percent of the patients requiredMODS, and underlying medical history. Variables with
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Table 3. Multivariate proportional hazard analysis of predictors of
high mortality in the absence of MODS
Variable RR CI x2 P value
Albumin #35 g /liter 3.6 0.9–14.4 3.4 0.06
Cholesterol
#150 mg/dl (#3.9 mmol /liter) 4.7 1.3–16.9 5.7 0.02
Sepsis 5.5 1.7–18.1 7.8 0.005
Oliguria 11.9 3.5–40.1 15.9 ,0.0001
Abbreviations are in Table 2 legend.
mmol/liter), and the mean difference in serum creatinine
levels between survivors and nonsurvivors was 10.7 mg/dl
(62 mmol/liter, P 5 0.4). The underlying medical condi-
tions did not contribute significantly to mortality except
in patients with congestive heart failure (CHF) in whom
six of seven (86%) expired, and in patients with chronic
obstructive pulmonary disease (COPD) in whom two of
three (67%) also expired. We were unable to show any
Fig. 1. Histogram showing the documented etiology of acute renal definite relationship between age, electrolyte abnormali-
failure. Abbreviations are: Post-op, postoperative acute tubular necrosis ties, and mortality. Patients with Acquired Immunodefi-
(ATN); Drug Tox, all nephrotoxin-mediated causes such as contrast
ciency Syndrome (AIDS) were generally #40 years old,and aminoglycosides; Xtal, all crystal-related causes.
but only 12 of 27 (44%) died. Multiorgan failure carried
the highest RR of death. Multivariate logistic regression
analysis revealed that MODS was the most important
Table 2. Univariate analysis of select possible predictors of mortality
predictor of mortality. In the presence of MODS, the
Variable RR CI P value RR of death associated with all other variables was re-
Underlying history of CHF 0.05 0.01–0.5 0.01 duced and not significant. However, when MODS was
Gender 0.67 0.29–1.56 0.35 excluded from analysis, hypoalbuminemia #35 g/liter,
Plasma creatinine
hypocholesterolemia #150 mg/dl (#3.9 mmol/liter), pres-$3.0 mg/dl ($265.2 lmol /liter) 0.7 0.3–1.6 0.3
Age 1.01 0.99–1.03 0.27 ence of sepsis, and oliguria were predictive of high mor-
Albumin #35 g /liter 5.0 1.9–13.2 0.001 tality (Table 3). Although the RR of death associated
Cholesterol
with LA was high, it did not attain a significant P value#150 mg/dl (#3.9 mmol /liter) 7.4 2.7–20.3 ,0.0001
Sepsis 9.4 3.7–23.9 ,0.0001 in multivariate analysis. However, the likelihood ratio test
Mechanical ventilation 10.8 2.8–41.0 0.0005 attained a P value of ,0.05, and hence it is included in
Oliguria 17.0 6.2–46.6 ,0.0001
Table 3. Further analysis of patients with sepsis revealedMODS 24.7 10.3–59.1 ,0.0001
that 52% had cholesterol ,150 mg/dl (3.9 mmol/liter)Abbreviations are: MODS, multiple organ dysfunction states; CI, 95% confi-
dence interval; RR, relative risk; CHF, congestive heart failure. Variable are as compared to 47% with cholesterol .150 mg/dl (3.9
arranged in increasing order of RR. mmol/liter, P 5 0.2). Similar analysis for albumin showed
that 53% of septic patients versus 46% of nonseptic
patients had an albumin level ,35 g/liter (P 5 0.1). Using
a prior probability of 0.5, our model classification yieldeddialysis; however, 50% of those who were dialyzed died.
a total correct classification of 83% (data not shown).The overall mortality was 39%, but 14 of 17 patients
Figures 2 and 3 show the relationship between LA(82%) admitted to the ICU expired. The causes of ARF
and LC with survival. The mean albumin level amongas documented in the charts are shown in Figure 1. Sixty
patients who died was 27 6 7 g/liter as compared withpercent of the cases resulted from intrarenal causes; 30%
34 6 7 g/liter in survivors (P , 0.0001). At censoring,were prerenal, and 10% were postrenal.
82% of cases with albumin .35 g/liter were alive com-
Outcome pared with 48% of those with albumin #35 g/liter (x2 5
11.9, P 5 0.0006). The mean cholesterol level amongThe main outcome of interest in this study was mortal-
nonsurvivors was 121.2 6 34 mg/dl (3.2 6 0.9 mmol/ity. Table 2 shows the results of the univariate analysis
liter) vs. 165.6 6 54 mg/dl (4.3 6 1.4 mmol/liter) inand the RR of mortality associated with various charac-
survivors (P , 0.0001). Also, at censoring, 85% of casesteristics. Age, gender, and plasma creatinine levels did
with cholesterol .150 mg/dl (.3.9 mmol/liter) were alivenot portend adverse outcome. The mean plasma creati-
nine level in survivors was 5.9 6 4.4 mg/dl (521.6 6 389 compared with 44% of those with cholesterol #150 mg/dl
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Fig. 2. Kaplan–Meier cumulative (Cum) survival plot for serum albu- Fig. 4. Regression plot showing the association between cholesterol
min. Symbols are: (h) event times in patients with albumin . 35 and albumin (Y 5 2.13 1 0.007X; R2 5 0.18).
g/liter; (s) albumin # 35 g/liter.
shadowed the risks associated with other factors. The
literature is replete with reports identifying age and gen-
der as either predictors [6, 7] or nonpredictors of mortal-
ity [1, 2, 14]. We were unable to show age as a risk factor
for mortality. Like other investigators, we observed a
male predominance in the incidence of ARF [1, 6, 7, 14]
but were unable to show male gender as a risk factor
for mortality. The role of gender as an adverse outcome
predictor remains questionable. A recent study reported
a male gender-related mortality RR of 2.0 [1].
A plasma creatinine level $ 3.0 mg/dl ($ 265.2 mmol/
liter) [2] has been reported to be predictive of high mor-
tality in ARF. In contrast, high serum creatinine levels
have been associated with lower mortality risk in patients
with ESRD [15], whereas ESRD patients with low serum
creatinine concentrations have higher mortality [9]. We
were unable to relate the creatinine level to mortalityFig. 3. Kaplan–Meier survival plot for cholesterol. Symbols are: ( )
in this study even when patients with serum creatinine ,event times in patients with serum cholesterol . 150 mg/dl; (s) choles-
terol # 150 mg/dl (# 3.9 mmol/liter). 3.0 mg/dl (265.2 mmol/liter) were excluded from analysis.
Indeed, the mean difference in plasma creatinine levels
between survivors and nonsurvivors was not significant.
Low plasma creatinine levels may be observed in ad-(#3.9 mmol/liter, x2 5 17.3, P , 0.0001). Figure 4 dis-
vanced renal failure as a result of decreased muscle mass,plays the association between albumin and cholesterol
malnutrition, advanced age, and chronic liver disease. It(R 5 0.4, P , 0.0001).
is not surprising, therefore, that the creatinine level often
bears no obvious hazard risk in ARF.
DISCUSSION The high mortality associated with LA in patients with
ESRD has been well documented [8–10, 15], but its roleThis study primarily involved patients with de novo
ARF and sought to identify factors that were predictive in ARF has not been clarified. In a study involving over
15,000 acutely ill patients, admission serum albumin , 34of high mortality. We have confirmed previously pub-
lished observations concerning the role of oliguria, sep- g/liter was reported to be a strong predictor of mortality,
prolonged length of stay, and readmission [16]. Of note,sis, MODS, ICU stay or mechanical ventilation and car-
diovascular complications as predictors of high mortality ARF was not included as a variable associated with in-
hospital death in that study. It was not until recently thatin ARF [1, 4–7]. Multiple organ failure was the most
significant predictor of mortality and essentially over- Chertow et al reported that LA was associated with an
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RR of 0.56 with respect to mortality or dialysis in their cant correlation between the combination of LA and LC
with sepsis.patients with ARF [1]. Our study is in agreement with
We recognize that some concerns exist regarding thistheir findings, although we observed a much higher RR
study, which include: the low percentage of patients re-of death when we employed both univariate and multi-
quiring dialysis, our inclusion criteria for ARF with avariate logistic regression analysis. The albumin level is
lower creatinine [that is, $2.0 mg/dl (177 mmol/liter)]generally regulated by dietary protein intake; hence,
than other studies have used, and the fact that all studymost studies in ESRD patients have concluded that LA
patients were African Americans living in an inner cityis a consequence of visceral protein malnutrition. In ex-
locale. The need for dialysis among patients with ARFperimental models, renal failure per se neither suppresses
is variable. Studies report a range of incidence rates fromalbumin synthesis nor results in a reduced albumin pool
36% [27] to a range of 46 to 86% in a study of predomi-[17, 18]. However, accelerated protein breakdown is a
nantly ICU patients [6]. Our comparatively low rate ofhallmark of metabolic alterations in ARF. Protein catab-
10% reflects the inclusion of a significant number ofolism in this setting has been attributed to the acute
patients with metastatic neoplastic conditions, severedisease process, uremic toxins, inflammatory mediators,
cardiomyopathy, and terminal AIDS who were eithermetabolic acidosis, circulating proteases, hormonal im-
not offered or who refused dialysis. Family members ofbalance, and insulin resistance among other factors [19].
such patients as well as the patients were involved in allAlbumin has been demonstrated to be a negative acute-
aspects of the decision to withhold dialysis. There is nophase reactive protein; that is to say, its synthesis is
consensus about either the level or the rate of rise ofsuppressed in response to inflammatory conditions [20].
creatinine that constitutes ARF. Chertow et al selectedKaysen, Stevenson, and Depner examined the relation-
a creatinine change of $1.0 mg/dl (88 mmol/liter) [1],ship between serum albumin and serum levels of two
whereas Brivet et al chose a level $3.5 mg/dl (308 mmol/positive acute-phase proteins, c-reactive protein (CRP)
liter) [6]. Of note, many studies have used a creatinineand serum amyloid A (SAA) in 115 hemodialysis pa-
level of $2.0 mg/dl (177 mmol/liter) as the defining crite-tients [21]. In confirmation of the earlier observation,
rion for ARF [27–29] in keeping with our criterion. Fi-they found that both CRP and SAA were inversely re-
nally, the ethnic origin and implied socioeconomic statuslated with albumin.
of our patients should not alter the findings in this study.Hypocholesterolemia has also been reported to be a
With the exception of LA and LC, all other predictorspredictor of high mortality in ESRD [10] and in the older
of mortality in ARF identified in this study have beenpopulation [11, 22]. However, the relationship between
well documented [1, 4, 7]. There is no reason to suspectLC and noncardiovascular-related mortality remains un-
that LA and LC are unique to African Americans. Aresolved [23]. Concentrations of total cholesterol have
review of data from the National Center for Health Sta-been reported to be reduced as part of an acute-phase
tistics revealed that serum albumin was positively corre-response analogous to that of albumin in hemodialysis
lated with serum cholesterol and, furthermore, that otherpatients [24]. Hypocholesterolemia and low high-density
cardiovascular risk factors correlated with serum albu-lipoproteins (HDLs) [25] have been described in criti-
min in both whites and blacks [30].cally ill surgical ICU patients with evidence of sepsis.
We believe that our findings are timely and shouldSubsequent to experiments that suggested that lipopro-
stimulate further prospective examination with betterteins play a role in binding and neutralization of endo-
indices of nutritional status in a more diverse ethnictoxin [26], Gordon et al suppressed lipopolysaccharide-
population. The presence of LA and LC in patients withstimulated production of tumor necrosis factor-a (TNF-a)
ARF should be seriously considered among factors otherby infusion of reconstituted HDL preparation into their
than merely evidence of poor nutrition alone as impetusseptic patients [25]. Although these authors did not cor-
for more aggressive management of patients. However,relate survival with lipid concentrations, a recent report
the extent that both LA and LC may reflect poor nutri-[24] found a significant relationship between both tumor
tional status, the effects of which are well known tonecrosis factor-a (TNF-a) and interleukin-6 (IL-6) and
be associated with higher morbidity and mortality inthe degree of LA and LC in their patients. They observed
hospitalized patients, warrants aggressive nutritional re-that IL-6 was the strongest predictor of mortality. In a
pletion and supplementation.recent study, we observed that LA and LC were highly
predictive of mortality. It is provocative that albumin and
ACKNOWLEDGMENTScholesterol levels showed a weak but highly significant
association, implying commonality in their etiology. This This study was partially supported by Grant #S-469, awarded to
C.I.O. by Dialysis Clinics, Inc., Nashville, TN, USA. We express sincerecommonality may be related to nutrition, uremic toxins,
gratitude to Robert Oster, Ph.D. (biostatistician), for his review and
or inflammatory mediators. Sepsis appeared to be an helpful suggestions for the statistical analysis, and to Ms. Sylvia Wadley
for help with the preparation of the manuscript.unlikely factor because we were unable to show a signifi-
Obialo et al: Predictors of mortality in ARF 1063
Reprint requests to Chamberlain I. Obialo, M.D., Department of failure in adults: Results of a community based study. BMJ 306:481–
483, 1993Medicine, Morehouse School of Medicine, 720 Westview Drive, S.W.,
Atlanta, Georgia 30310, USA. 15. Culp K, Flanigan M, Lowrie EG, Lew N, Zimmerman B: Model-
ing mortality risk in hemodialysis patients using laboratory values
as time-dependent covariates. Am J Kidney Dis 28:741–746, 1996
REFERENCES 16. Herrmann FR, Safran C, Levkoff SE, Minaker KL: Serum albu-
min level on admission as a predictor of death, length of stay and1. Chertow GM, Lazarus JM, Paganini EP, Allgren RL, Lafay-
readmission. Arch Intern Med 152:125–130, 1992ette RA, Sayegh MH: Predictors of mortality and the provision
17. Kaysen GA, Watson JB: Mechanism of hypoalbuminemia in theof dialysis in patients with acute tubular necrosis. J Am Soc Nephrol
7/8 nephrectomized rat with chronic renal failure. Am J Physiol9:692–698, 1998
243:F372–F378, 19822. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT:
18. Zern MA, Yap SH, Strair RK, Kaysen GA, Shafritz DA: TheHospital-acquired renal insufficiency: A prospective study. Am J
effects of chronic renal failure on protein synthesis and albuminMed 74:243–248, 1983
mRNA in the rat liver. J Clin Invest 73:1167–1174, 19843. Biesenbach G, Zazgornik J, Kaiser W, Grafinger P, Stuby U,
19. Druml W: Protein metabolism in acute renal failure. Miner Elec-Necek S: Improvement in prognosis of patients with acute renal
trolyte Metab 24:47–54, 1998failure over a period of 15 years: An analysis of 710 cases in a
20. Moshage HJ, Jansen JAM, Franssen JH, Hafkenscheid JCM,dialysis center. Am J Nephrol 12:319–325, 1992
Yap SH: Study of the molecular mechanisms of decreased liver4. Levy EM, Viscoli CM, Horwitz RI: The effect acute renal failure
synthesis of albumin in inflammation. J Clin Invest 79:1635–1641,on mortality. JAMA 275:1489–1494, 1996
19875. Shusterman N, Strom BL, Murray TG, Morrison G, West SL,
21. Kaysen GA, Stevenson FT, Depner TA: Determinants of albuminMaislin G: Risk factors and outcome of hospital-acquired acute
concentration in hemodialysis patients. Am J Kidney Dis 29:658–renal failure. Am J Med 83:65–71, 1987
668, 19976. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJM: Acute renal
22. Noel MA, Smith TK, Ettinger WH: Characteristics and outcomesfailure in intensive care units-causes, outcome, and prognostic fac-
of hospitalized older patients who develop hypocholesterolemia.tors of hospital mortality: A prospective, multicenter study. Crit
J Am Geriatr Soc 39:455–461, 1991Care Med 24:192–198, 1996
23. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, Mcmillan7. Bullock ML, Umen AJ, Finkelstein M, Keane WF: The assess- G, Neaton J, Potter J, Rifkind B: Report of the conference onment of risk factors in 462 patients with acute renal failure. Am low blood cholesterol: Mortality associations. Circulation 86:1046–J Kidney Dis 5:97–103, 1985 1060, 1992
8. Owen WF, Lew NL, Liu Y, Iowrie EG, Lazarus JM: The urea 24. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Sten-
reduction ratio and serum albumin concentration as predictors zel KH, Rubin AL: Interleukin-6 predicts hypoalbuminemia, hy-
of mortality in patients undergoing hemodialysis. N Engl J Med pocholesterolemia and mortality in hemodialysis patients. Am J
329:1001–1006, 1993 Kidney Dis 32:107–114, 1998
9. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The 25. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JCL, Sloan
predictive value of commonly measured variables and an evalua- BJ, Barie PS, Rubin AL: Low lipid concentrations in critical illness:
tion of death rate differences between facilities. Am J Kidney Dis Implications for preventing and treating endotoxemia. Crit Care
15:458–482, 1990 Med 24:584–589, 1996
10. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P: 26. Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP,
Markers for survival in dialysis: A seven-year prospective study. Jones AL, Eichbaum EB, Bland GF, Rapp JH: Chylomicrons
Am J Kidney Dis 26:209–219, 1995 alter the fate of endotoxin, decreasing tumor necrosis factor release
11. Grant MD, Piotrowski ZH, Miles TP: Declining cholesterol and and preventing death. J Clin Invest 91:1028–1034, 1993
mortality in a sample of older nursing home residents. J Am Geriat 27. Liano F, Pascual J: Epidemiology of acute renal failure: A pro-
Soc 44:31–36, 1996 spective, multicenter, community-based study. Kidney Int 50:811–
12. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung 818, 1996
CL, Sibbald WJ: Multiple organ dysfunction score: A reliable 28. Kaufman J, Dhakal M, Patel B, Hamburger R: Community-
descriptor of a complex clinical outcome. Crit Care Med 23:1638– acquired acute renal failure. Am J Kidney Dis 17:191–198, 1991
1652, 1995 29. Mayr A, Deusch E, Hasibeder W, Mutz N: Acute renal failure
13. Lemeshow S, Le Gall J: Modeling the severity of illness of ICU in intensive care units. Crit Care Med 24:1930–1931, 1996
patients. JAMA 272:1049–1055, 1994 30. Gillum RF: The association between serum albumin and HDL
14. Feest TG, Round A, Hamad S: Incidence of severe acute renal and total cholesterol. J Natl Med Assoc 85:290–292, 1993
